ÐÏࡱá>þÿ 35þÿÿÿ2ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Á€ ð¿©bjbj´V´V 4Ö<Ö<© ÿÿÿÿÿÿ·Ø Ø ÿÿÿÿ//// ;/æ >OOOOO***‰ ‹ ‹ ‹ ‹ ‹ ‹ $#¢Æ%B‹ *****‹ OOÛ  ÖÖÖ*‚OO‰ Ö*‰ ÖÖ:‰,íOÿÿÿÿ0F«ˆ¡mÌ/¬ µ u ¶ 0æ ¿.&¶&í&íˆ**Ö*****‹ ‹ Æ***æ ****ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ&*********Ø á: DRUG DEVELOPMENT AND DRUG SAFETY (MSc/PgDip with a view to transfer to MSc/PgDip/PgCert) 57B2DSB1/61B2DSB1/61B2DSVX/62B2DSVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Medicine, Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biomedical Sciences, Biology). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers/research in the development and safety assessment of new and current drugs. To achieve this, the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug-induced toxicity; preclinical and clinical trials; regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and small group demonstrations in laboratories and clinical departments. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion, with an emphasis on humans; molecular biology and bioanalytical methods e.g. mass spectroscopy; mechanisms of drug-induced toxicity, reproductive toxicology, immunotoxicology and neurotoxicology; pharmacokinetics; toxicokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the design and conduct of volunteer and clinical trials; assessment of drug safety. Candidates shall be required to attend the following designated programme of courses: Stage 1 GS 50M1 Generic Skills (0 credit points) MT 5010 Basic Skills – Induction (0 credit points) MT 5011 Molecular Pharmacology, immunology and Oncology (15 credit points) MT 5012 Human Drug Metabolism and Molecular Toxicology (20 credit points) MT 5013 Therapeutics for Scientists (5 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Elective MB 5015 Molecular Biology Basics & Cloning Lab (15 credit points) Stage 2 MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5508 Clinical Pharmacology (5 credit points) MT 5509 Pharmacokinetics and Toxicokinetics (10 credit points) MT 5510 Introduction to Research Methods (10 credit points) Elective MT 55EP Careers & Employability for Postgraduates (5 credit points) Stage 3 MT 5900 Research Project (70 credit points) Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The thesis/dissertation will be assessed and there may be an oral examination on completion of the programme. Yb}~˜Q Z Â Æ   )0 y€¯º§¨©öèÝèöÒöÒöÒöÒöÇöÇöÇöÒöº³ hå-ÚhïCJhœy½húsIOJQJ^JhúsI>*OJQJ^JhúsI6�OJQJ^JhúsI5�OJQJ^JhýÈhúsI5�OJQJ^JhúsIOJQJ^JY~P Q Á    Ñ Ò ()12[ŽÙ#Y‡´µ¾¿óêóååååååååååååÜÜÜÜÜÜÜÜÜÜ Æ„gdúsIgdúsI ÆD%gdúsI  Æ 0D%gdúsI¿  7~®í)*34xy�‚®¯¨©öööööööööööööööööööñgdå-Ú Æ„gdúsI21�h:p[=°‚. °ÆA!° "° #� $� %°°Ä°Ä �Äj ˜žžžžžžž666666666vvvvvvvvv66666>666666666666666666666666666¨6666666666¸6666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€�ÀÐàð2(Øè 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�8XøV~ OJPJQJ_HmH nH sH tH N`ñÿN ° Normal$a$ CJOJPJQJ_HmH sH tH `` „+´� Heading 2$¤ð¤<@&$5�6�CJOJPJQJ\�]�^JaJ>@> °  Heading 3$d8ÿ@&5�XX î=� Heading 6 ¤ð¤<@&5�CJOJPJQJ\�^JaJRR "2^� Heading 7 ¤ð¤<@&CJOJPJQJ^JaJXX N$Ð� Heading 8 ¤ð¤<@&6�CJOJPJQJ]�^JaJDA òÿ¡D Default Paragraph FontRióÿ³R 0 Table Normalö4Ö l4Öaö (k ôÿÁ( 0No List Pþ¢ñP ° Heading 3 Char5CJOJPJQJ^JaJ\þ¢\ „+´�Heading 2 Char(56CJOJPJQJ\]^JaJtH 44 „+´Header  Æ9r Bþ¢!B „+´ Header CharCJOJPJQJtH Vþ¢1V î=�Heading 6 Char"5CJOJPJQJ\^JaJtH Pþ¢AP "2^�Heading 7 CharCJOJPJQJ^JaJtH JZRJ w�0 Plain Text$a$CJOJQJ^JtH Fþ¢aF w�0Plain Text CharOJPJQJ^JVQrV ft Body Text 3$ Æ0d6ÿa$ 5�OJQJPþ¢�P ftBody Text 3 Char5CJOJPJQJtH Vþ¢‘V N$Ð�Heading 8 Char"6CJOJPJQJ]^JaJtH 6U¢¡6 mOÛ Hyperlink >*B*phÿPK!‚мú[Content_Types].xml¬‘ËjÃ0E÷…þƒÐ¶Ørº(¥ØÎ¢Iw},Òä±-j�„4 Éßwì¸Pº-t#bΙ{U®�ã “óTéU^h…d}㨫ôûî)»×*1Pƒ'¬ô “^××Wåî0)™¦Též9<“l�#¤Ü$yi}�å;À~@‡æ¶(îŒõÄHœñÄÐuù* D× zƒÈ/0ŠÇ° ðûù $€˜ X«Ç3aZ¢ÒÂà,°D0j~è3ß¶Îbãí~i>ƒØÍ3¿\`õ?ê/ç[ج¶Géâ\Ä!ý-ÛRk.“sþÔ»�..—·´aæ¿­?ÿÿPK!¥Ö§çÀ6 _rels/.rels„�ÏjÃ0 ‡ï…½ƒÑ}QÒÃ%v/¥�C/£}á(h"ÛëÛOÇ »„¤ï÷©=þ®‹ùá”ç šªÃâC?Ëháv=¿‚É…¤§%[xp†£{Ûµ_¼PÑ£<Í1¥H¶0•ˆÙO¼R®BdÑÉÒJEÛ4b$§‘q_טžà6LÓõR×7`®�¨Éÿ³Ã0ÌžOÁ¯,åEn7”Liäb¡¨/ãS½�¨eªÔе¸ùÖýÿÿPK!ky–ƒŠtheme/theme/themeManager.xml ÌM à @á}¡w�Ù7c»(Eb²Ë®»öCœAÇ ÒŸÛ×åãƒ7ÎßÕ›K Y,œ ŠeÍ.ˆ·ð|,§¨ÚHÅ,láÇæéxÉ´�ßIÈsQ}#Õ�…­µÝ Öµ+Õ!ï,Ý^¹$j=‹GWèÓ÷)âEë+& 8ýÿÿPK!–µ­â–Ptheme/theme/theme1.xmlìYOoÛ6¿Øw toc'vuŠØ±›-MÄn‡i‰–ØP¢@ÒI}Úã€úa‡Øm‡a[�Ø¥û4Ù:lЯ°GR’ÅX^’6ØŠ­>$ùãûÿ©«×îÇ !)OÚ^ýrÍC$ñy@“°íÝö/­yH*œ˜ñ„´½)‘Þµ�÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ�©OÐP“ô6râ=¯‰’zÀgb Ig…Áu��SÙebÖö€OÀ�†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0­÷­+[}`j×ëõº½zAϰV–2ÍF­ÞÉi–@öqžv·Ö¬5\|‰þʜ̭N§Óle²X¢dsøµÚjcsÙÁ�Å7çð�Îf·»êà ÈâWçðý+­Õ†‹7 ˆÑä`­ÚïgÔ È˜³íJøÀ×j|†‚h(¢K³óD-еß㢠dXÑ©iJÆØ‡(îâx$(Ö ð:Á¥;ä˹!Í I_ÐTµ½S 1£÷êù÷¯ž?EÇž?øéøáÃã?ZBΪmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&΋/ŸüöìÉ‹¯>ýý»GðM�Geø�ÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:ĵàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€� íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i ~™Vé þvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘☕ ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*ݾ˦±‹ŠTѼ�9/#·øA7ÂqZ…Ð$*c?�¢íqUßån†èwðNºû%Ž»O¯·ièˆ4 =3Ú—Pª� ÓäïÊ1£P�m \\9†øâëÇ‘õ¶âMØ“ª2aûDù]„;Yt»\ôí¯¹[x’ìóù�ç]É}Wr½ÿ|É]”Ïg-´³Ú eW÷ ¶)6-r¼°CSÆjÊÈ išd ûDЇA½ÎœIqbJ#xÌ꺃 6k�àê#ª¢A„Sh°ëž&ÊŒt(QÊ%ìÌp%m�‡&]ÙcaSl=�XíòÀ¯èáü\P�1»MhŸ9£Mà¬ÌV®dDAí×aV×B�™[݈fJ�íP|8¯ Ö„AÛV^…ó¹f ÌH ín÷ÞÜ-Æ é"á€d>ÒzÏû¨nœ”ÇŠ¹ €Ø©ð‘>ä�bµ·–&ûÜÎâ¤2»Æv¹÷ÞÄKyϼ¤óöD:²¤œœ,AGm¯Õ\nzÈÇiÛÙã¼.uχYC¾6ìOMf“å3o¶rÅÜ$¨Ã5…µûœÂNH…T[XF64ÌT,Ñœ¬üËM0ëE)`#ý5¤XYƒ`ø×¤;º®%ã1ñUÙÙ¥m;ûš•R>QD ¢à�ØDìcp¿UÐ' ®&LEÐ/p�¦­m¦Üâœ%]ùöÊàì8fi„³r«S4Ïd 7y\È`ÞJâ�n•²åίŠIù R¥Æÿ3Uô~7+�ö€׸#�¯m� q¨BiDý¾€ÆÁÔˆ¸‹…i*¸L6ÿ9ÔÿmÎY&­áÀ§öiˆ…ýHE‚�=(K&úN!VÏö.K’e„LD•Ä•©{D 긪÷vEꦚdeÀàNÆŸûžeÐ(ÔMN9ßœRì½6þéÎÇ&3(åÖaÓÐäö/D¬ØUíz³<ß{ËŠè‰Y›Õȳ˜•¶‚V–ö¯)Â9·Z[±æ4^næÂ�ç5†Á¢!Já¾é?°ÿQá3ûeBo¨C¾µÁ‡M ¢ú’m<�.�vp�“´Á¤IYÓf­“¶Z¾Y_p§[ð=al-ÙYü}NcÍ™ËÎÉÅ‹4vfaÇÖvl¡©Á³'S†ÆùAÆ8Æ|Ò*uâ£{àè-¸ßŸ0%M0Á7%�¡õ˜<€ä·ÍÒ�¿ÿÿPK! Ñ�Ÿ¶'theme/theme/_rels/themeManager.xml.rels„�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!‚мú[Content_Types].xmlPK-!¥Ö§çÀ6 +_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!–µ­â–PÑtheme/theme/theme1.xmlPK-! Ñ�Ÿ¶'› theme/theme/_rels/themeManager.xml.relsPK]– © ÿÿÿÿ© ¿© ð8ð@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðS ð¿Ëÿ ?ð&+KPQW¹¾WdÃÓØçû $ËÙ« « ¨ « ¨ « zûp>ë�ÿÿÿÿÿÿÿÿÿ´}ŽzÀí³ú‚ÿÿÿÿÿÿÿÿÿ„<„˜þÆ<^„<`„˜þo(.„ª„˜þƪ^„ª`„˜þo(()‚„z„LÿÆz^„z`„Lÿ.€„J „˜þÆJ ^„J `„˜þ.€„ „˜þÆ ^„ `„˜þ.‚„ê„LÿÆê^„ê`„Lÿ.€„º„˜þƺ^„º`„˜þ.€„Š„˜þÆŠ^„Š`„˜þ.‚„Z„LÿÆZ^„Z`„Lÿ. „Є˜þÆÐ^„Ð`„˜þOJQJo(·ð€„ „˜þÆ ^„ `„˜þOJQJ^Jo(o€ „p„˜þÆp^„p`„˜þOJQJo(§ð€ „@ „˜þÆ@ ^„@ `„˜þOJQJo(·ð€„„˜þÆ^„`„˜þOJQJ^Jo(o€ „à„˜þÆà^„à`„˜þOJQJo(§ð€ „°„˜þư^„°`„˜þOJQJo(·ð€„€„˜þÆ€^„€`„˜þOJQJ^Jo(o€ „P„˜þÆP^„P`„˜þOJQJo(§ð´}Žzzûpÿÿÿÿÿÿÿÿÿÿÿÿ         \åYÀ “BkwgH æJ&d° î=gu(,¥v“[!ú)"ƒZ%l.â3üg8…x;[=Q@B|BúsIïCJqKLØyLw}MmOgNPk,QEuW¥^]"2^H_×aƒ;aMVataèEc°Fe%'gQ=gy&jDzj\AlÍ9oø(tftv¥YxH y%z7g|4&}?7}sl…ÞŠ aŠ”=�w� ~•Þ(˜­u˜.œt9 Æa«í¬’j¯ °„+´‹·±M¹7RÃ.È”~ÌN$ÐhÔå-ÚmOÛé|Þ¦5àð$âËmçg;èûSêïdñz9ñÜBõ}%ùR9ýgþ© « ÿ@© €@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿ G�ï*àAxÀ ÿTimes New Roman5�€Symbol3.� ÿ*àCxÀ ÿArial7.�ï { @ŸCalibriY� CG TimesTimes New Roman7�ï K@ŸCambria?=� ÿ*àCxÀ ÿCourier New;�€WingdingsA�ï ë BŸCambria Math"qˆðÐhƒ=ùfƒ=ùf— �— !ð  ´´��r0¤ ¤ 3ƒðüýHP ðÿ$Päÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ° 2!xx ÿÿRobertRobert  þÿà…ŸòùOh«‘+'³Ù0 pxˆ˜ ¨´ Ô à ìøäRobertNormalRobert2Microsoft Office Word@FÃ#@Úv†¡mÌ@Úv†¡mÌ— þÿÕÍÕœ.“—+,ù®0è hp|„Œ” œ¤¬´ ¼ Éä¤   Title þÿÿÿ !þÿÿÿ#$%&'()þÿÿÿ+,-./01þÿÿÿýÿÿÿ4þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀF€z®ˆ¡mÌ6€1Tableÿÿÿÿÿÿÿÿ&WordDocumentÿÿÿÿÿÿÿÿ4SummaryInformation(ÿÿÿÿ"DocumentSummaryInformation8ÿÿÿÿÿÿÿÿÿÿÿÿ*CompObjÿÿÿÿÿÿÿÿÿÿÿÿyÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.8ô9²q